Health
China SXT Pharmaceuticals, Inc. Enters into Non-Binding LOI to Acquire Jiangsu Renji Pharmaceutical Chain Co., Ltd.
TAIZHOU, China, Feb. 11, 2021 /PRNewswire/ -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company") announced today that it has entered into a non-binding letter of intent with Jiangsu Renji Pharmaceutical Chain Co., Ltd. ("Renji Chain"). Pursuant to the terms of the LOI,...
2021-02-11 21:00
4192
GenScript Receives FDA Emergency Use Authorization for Use of cPass(TM) SARS-CoV-2 Neutralization Antibody Test in Convalescent Plasma Screening
PISCATAWAY, N.J., Feb. 11, 2021 /PRNewswire/ -- GenScript USA Inc
2021-02-11 20:30
1758
Transcenta Holding Announces Appointment of Dr. Michael Shi as Executive Vice President, Head of Global R&D and Chief Medical Officer
SUZHOU, China, Feb. 10, 2021 /PRNewswire/ -- Transcenta Holding Limited (Transcenta), a global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, today announced the appointment of Dr.Michael Shi as Executive Vic...
2021-02-11 08:00
1908
VolitionRx Limited Announces Pricing of $20 Million Underwritten Public Offering of Common Stock
AUSTIN, Texas, Feb. 10, 2021 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company that applies its Nucleosomics™ platform through its subsidiaries to develop simple, easy to use, cost-effective blood tests to help diagnose a range of cancers ...
2021-02-10 22:18
9717
I-Mab Announces China NMPA Clearance for Phase 1 Study of TJ210/MOR210 in Patients with Advanced Solid Tumors
SHANGHAI and GAITHERSBURG, Md., Feb. 10, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced that the Center for Drug Evaluation (CDE) of the China N...
2021-02-10 21:00
5548
Tessa Therapeutics Announces Successful Dosing of First Patient Cohort in Phase I Allogeneic Cell Therapy Trial
BEDMINSTER, N.J. and SINGAPORE, Feb. 10, 2021 /PRNewswire/ -- Tessa Therapeutics Ltd. (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments for hematological malignancies and solid tumors, today announced the successful completion of dosing of the first pati...
2021-02-10 19:12
2118
$16 Million Capital Raise to Progress Bionomics BNC210 PTSD Trial
* Commitments received for a placement of A$15,991,634 at A$0.145 per share * Significant participation from North American and European institutional and sophisticated investors * This capital raising enables proceeding with the Phase 2b PTSD trial in mid-2021 as planned and sees the Compan...
2021-02-10 19:00
8608
Xi: China ready to cooperate with CEE countries on vaccines
BEIJING, Feb. 10, 2021 /PRNewswire/ -- China Daily: A highlight from President
Xi Jinping's keynote speech at the virtual China-CEEC Summit inBeijing, Feb 9,
2021.
2021-02-10 17:43
2317
WAT Medical's Co-Founder receives UC Berkeley's 2021 Student Innovator Award
VANCOUVER, BC, Feb. 9, 2021 /PRNewswire/ -- WAT Medical Co-Founder, Peter Ji, has received UC Berkeley's 2021 Student Innovator Award The Berkeley Student Innovator Award is an annual school-wide competition sponsored by VSP through Jobson's Rick Bay Foundation for Excellence in Eyecare Educatio...
2021-02-09 22:00
1601
Alterity Therapeutics announces funding from Michael J. Fox Foundation for ATH434 dose optimization for Parkinson's disease clinical trials
NEW YORK, Feb. 9, 2021 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company") has today announced the award of a grant from The Michael J. Fox Foundation for Parkinson's Research to determine optimal dosing of its lead drug candidate ATH434 for Parkinson's di...
2021-02-09 21:53
3753
Neurophth Closes RMB 400 Million Series B Financing
Proceeds to support – * continued development of robust portfolio of AAV-delivered therapeutics with IND initiation of ND4-mediated LHON planned in 2021 * completion of Suzhou GMP manufacturing facility in accordance with the international quality standards planned in 2021 * initiation of ...
2021-02-09 21:44
2200
Crisis and Opportunity Coexist: The Battle to Defend the Survival of Online Entertainment in the Pandemic (Part 2) - Interview with Color Star Technology Co., Ltd. (NASDAQ: CSCW)
NEW YORK, Feb. 9, 2021 /PRNewswire/ -- Recently, Luke Lu, CEO of Color Star Technology Co., Ltd. (Nasdaq: CSCW) (hereinafter referred to as "CSCW"), accepted an interview with the HK Finet Group. Mr. Lu provided the following responses regarding CSCW's corporate breakthroughs and development in r...
2021-02-09 21:00
7609
Registered Secondary Public Offering of American Depositary Shares by Certain Pre-IPO Shareholders of I-Mab Has Priced
SHANGHAI and GAITHERSBURG, Md., Feb. 9, 2021 /PRNewswire/ -- A registered follow-on public offering by certain pre-IPO shareholders (the "Selling Shareholders") of 3,283,950 American depositary shares (the "ADSs" and such offering, the "ADS Offering") of I-Mab (the "Company") (Nasdaq: IMAB), a c...
2021-02-09 21:00
9682
MDBriefCase Establishes World-Class Oncology Scientific Steering Committee
Leading global oncology professionals to identify areas of opportunity for educational programs worldwide TORONTO, Feb. 9, 2021 /PRNewswire/ -- MDBriefCase Group Inc. ("MDBriefCase"), a global provider of leading online continuing medical education and professional development for healthcare pro...
2021-02-09 19:00
1176
Chinese Aesthetic Treatment Industry White Paper 2020 Jointly Released By AIH and Forbes China
SHENZHEN, China, Feb. 9, 2021 /PRNewswire/ -- Aesthetic Medical International Holdings Group Limited (the "Company" or "AIH", Nasdaq: AIH), a leading provider of aesthetic medical services inChina, and Forbes China have jointly releasedthe Chinese Aesthetic Treatment Industry White Paper 2020 (t...
2021-02-09 18:00
2901
Experiment showed that Jemincare's neutralizing antibody JMB2002 would likely keep the potency against the South African mutant
SHANGHAI, Feb. 8, 2021 /PRNewswire/ -- On February 7, 2021, scientists from Jemincare Shanghai Research Institute published a preprint paper on BioRxiv, the paper entitled "A human antibody with blocking activity to RBD proteins of multiple SARS-CoV-2 variants including B.1.351 showed potent prop...
2021-02-09 11:18
1952
Cooperation Agreement with Terumo Blood And Cell Technologies to Promote and Sell Osteopore Products
Highlights: * Cooperation Agreement with Terumo Blood and Cell Technologies to promote and sell both companies complementary regenerative products inAsia-Pacific. * Terumo Blood and Cell Technologies' products will be used to concentrate a patient's bone marrow and mixed into Osteopore scaffo...
2021-02-08 21:21
2202
Longevity Acquisition Corporation Announces 4D pharma Clinical Trial Collaboration and Supply Agreement for the Treatment of Locally Advanced or Metastatic Urothelial Carcinoma
NEW YORK, Feb. 8, 2021 /PRNewswire/ -- Longevity Acquisition Corporation (NASDAQ: LOAC) (the "Company"), a publicly-traded special purpose acquisition company, announced today that onFebruary 8, 2021, 4D pharma plc (AIM: DDDD) ("4D pharma"), a pharmaceutical company leading the development of Liv...
2021-02-08 21:00
7773
CareCapital appoints Bindusaran as Executive Director
HONG KONG, Feb. 8, 2021 /PRNewswire/ -- CareCapital Advisors Limited ("CareCapital") announces the appointment of Mr. A P A Bindusaran as Executive Director and Head of DSO Clinical and Business Development. Prior to joining CareCapital, Mr. Bindusaran spent 16 years in R&D, clinical affairs, tre...
2021-02-08 18:14
1902
Proposed Registered Secondary Public Offering of American Depositary Shares by Certain Pre-IPO Shareholders of I-Mab
SHANGHAI and GAITHERSBURG, Md., Feb. 5, 2021 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel biologics, today announced the commencement of a proposed registered underwritten pu...
2021-02-06 06:27
9582
Week's Top Stories
Most Reposted
Senetas and Nokia Announce Strategic Alliance to Secure Mission-Critical Networks for Defence and Government
[Picked up by 312 media titles]
2025-11-27 07:25World-Leading Microsurgeon Professor J.P. Hong Joins MediThinQ as CMO, Marking Strong Validation for Next-Generation Digital Microsurgery
[Picked up by 296 media titles]
2025-12-03 09:00
SpeQtre, the entanglement-based quantum comms demonstrator satellite, is now on orbit
[Picked up by 295 media titles]
2025-11-29 09:00
Blackpanda and ST Engineering Partner to Strengthen Cyber Incident Response Across Asia
[Picked up by 285 media titles]
2025-12-03 14:27
MetaOptics Announces Strategic Share Placement to Accelerate Growth and Meet Rising Global Demand
[Picked up by 284 media titles]
2025-12-01 08:30Most Read
MINISO Unveils Australia's First and Largest MINISO LAND Flagship at Sydney Chatswood
2025-11-27 18:56
2734
